Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Scientific Reports
|
May 7, 2020
Sexual Dimorphism of Metabolomic Profile in Arterial Hypertension
Yaya Goïta, Juan Manuel Chao de la Barca, Asmaou Keïta, et al.
Frontiers in Genetics
|
January 31, 2020
Data-Mining Approach on Transcriptomics and Methylomics Placental Analysis Highlights Genes in Fetal Growth Restriction
Floris Chabrun, Noémie Huetz, Xavier Dieu, et al.
Annales De Biologie Clinique
|
January 9, 2026
Clinical biology and artificial intelligence: Objectives of the SFBC Workgroup
Walid Sabeur, Pierre-Adrien Bihl, Bruno Gauthier, et al.
Nature Communications
|
April 8, 2026
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study
Omar Nadeem, Michelle P Aranha, Robert A Redd, et al.
Research Square
|
June 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)
Floris Chabrun, Daniel Schwartz, Susanna Gentile, et al.
Nature Medicine
|
March 25, 2026
Enhanced dynamic risk stratification of smoldering multiple myeloma
Floris Chabrun, Daniel E Schwartz, Susanna Gentile, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Scientific Reports
|
May 7, 2020
Sexual Dimorphism of Metabolomic Profile in Arterial Hypertension
Yaya Goïta, Juan Manuel Chao de la Barca, Asmaou Keïta, et al.
Frontiers in Genetics
|
January 31, 2020
Data-Mining Approach on Transcriptomics and Methylomics Placental Analysis Highlights Genes in Fetal Growth Restriction
Floris Chabrun, Noémie Huetz, Xavier Dieu, et al.
Annales De Biologie Clinique
|
January 9, 2026
Clinical biology and artificial intelligence: Objectives of the SFBC Workgroup
Walid Sabeur, Pierre-Adrien Bihl, Bruno Gauthier, et al.
Nature Communications
|
April 8, 2026
Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study
Omar Nadeem, Michelle P Aranha, Robert A Redd, et al.
Research Square
|
June 12, 2025
Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)
Floris Chabrun, Daniel Schwartz, Susanna Gentile, et al.
Nature Medicine
|
March 25, 2026
Enhanced dynamic risk stratification of smoldering multiple myeloma
Floris Chabrun, Daniel E Schwartz, Susanna Gentile, et al.
Page
of 4